[Molecular pathology analysis of the KRAS mutation status in patients with metastasized colorectal carcinoma: an initial approach using predictive pathology]. [electronic resource]
Producer: 20090520Description: 93-6 p. digitalISSN:- 1432-1963
- Angiogenesis Inhibitors -- therapeutic use
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents -- therapeutic use
- Bevacizumab
- Cetuximab
- Colorectal Neoplasms -- drug therapy
- DNA Mutational Analysis
- ErbB Receptors -- antagonists & inhibitors
- Genes, ras
- Humans
- Mutation
- Neovascularization, Pathologic -- drug therapy
- Prognosis
- Proto-Oncogene Proteins -- genetics
- Proto-Oncogene Proteins p21(ras)
- ras Proteins -- genetics
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.